Worldwide Biopsy Devices Industry to 2027 - Impact of COVID-19 -

·5 min read

DUBLIN, October 21, 2021--(BUSINESS WIRE)--The "Biopsy Devices Market Global Forecast 2021-2027, Impact of COVID-19, Size, Share, Insight, Growth, Opportunity Company Analysis" report has been added to's offering.

Worldwide, there is an increase in detection of cancer incidences, of Breast cancer, Prostate cancer, and Lung cancer, due to a rise in awareness level. Besides rapid technological advancements such as 3D optical biopsies, MRI-targeted biopsies, and Ultrasound-guided biopsies fuel the adoption of biopsy devices. Many countries hold programs for the early diagnosis of breast cancer. Therefore, such initiatives will stimulate the adoption rate of biopsy devices, thereby positively impacting the growth of the biopsy devices business. According to the publisher, the Global Biopsy Devices Market is projected to reach US$ 3.5 Billion by 2027.

Companies Mentioned

  • Becton Dickinson and Company

  • Cardinal Health Inc.

  • Braun Melsungen AG, Inc

  • Olympus Corporation

  • Boston Scientific Corporation

  • Medtronic plc

  • Hologic, Inc.

With improved screening and diagnostic techniques, biopsy devices are an integral part of the diagnostic workup for many medical conditions. It is a procedure to perform surgical removal of tissue from an organ to determine the presence or extent of disease, usually cancerous and inflammatory conditions. This diagnostic procedure is performed by radiologists, surgeons and interventional cardiologists. Biopsies can be done on any organ using specific biopsy devices as a confirmatory test for cancer and celiac diseases. According to the World Cancer Report, cancer rates could further increase by 50% to 15 Million new cases in 2020. Therefore, the increasing incidence of cancer cases and developments in biopsy devices witness high growth.

The biopsy devices market has been segmented into Biopsy Needles, Guidance Systems, Biopsy Guns, Reagents and others. Needle-based biopsy holds the leading market share due to the increasing demand for Fine Aspiration Needles and Core Needles for acquiring samples from soft tissues of internal organs, an application such as breasts, Prostate, and lungs. As per Statista, breast cancer will make up to 27.7 percent of all the new cancer cases in women in Asia in 2020.

In addition, Guidance Systems, Biopsy Guns, Reagents and other devices are used in extensive applications across numerous healthcare institutions, such as Diagnostic Center, Hospitals and others. Advanced healthcare infrastructure and the expanding prevalence of infections have positively impacted biopsy devices growth over the projected timeframe. This is attributed to the growth in the healthcare sector in emerging economies, the rise in out-of-pocket healthcare expenditure, and the increase in the number of hospitals. As per this research report, Worldwide Biopsy Devices Market is likely to grow at a CAGR of 6.86% by 2021 - 2027.

Further, North America is the leading revenue contributor in the biopsy devices market. It is due to the large availability of trained medical professionals, well-developed infrastructure facilities, and the presence of a majority of key players. Moreover, Asia Pacific is a promising destination for biopsy device manufacturers. Rapidly improving healthcare infrastructure in emerging Asia Pacific countries, coupled with high unmet patient needs and increasing incidence of breast cancer, is anticipated to stimulate the demand for biopsy devices. the research suggests that the Global Biopsy Devices Market was US$ 2.2 Billion in 2020.

Key Topics Covered:

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers

4.2 Challenges

5. Global Biopsy Devices Market

6. Market Share - Global Biopsy Devices

6.1 By Product

6.2 By Application

6.3 By Region

6.4 By End-User

7. Product - Biopsy Devices Market

7.1 Biopsy Needles

7.1.1 Fine Aspiration Needles

7.1.2 Core Needles

7.2 Guidance Systems

7.2.1 Ultrasound-guided

7.2.2 Stereotactic-guided

7.2.3 Clinically-guided

7.3 Biopsy Guns

7.4 Reagents and kits

7.5 Others (Brushes, Curettes and Punches etc)

8. Application - Biopsy Devices Market

8.1 Breast Biopsy

8.2 Lung Biopsy

8.3 Prostate Biopsy

8.4 Others

9. Region - Biopsy Devices Market

9.1 North America

9.2 Europe

9.3 Asia-Pacific

9.4 Rest of World

10. End User - Biopsy Devices Market

10.1 Diagnostic Center

10.2 Hospitals

10.3 Others

11. Company Analysis

11.1 Becton, Dickinson and Company

11.1.1 Overview

11.1.2 Recent Development

11.1.3 Financial Insight

11.2 B. Braun Melsungen AG

11.2.1 Overview

11.2.2 Key Development

11.2.3 Financial Insight

11.3 Cardinal Health, Inc.

11.3.1 Overview

11.3.2 Key Development

11.3.3 Financial Insight

11.4 Olympus Corporation

11.4.1 Overview

11.4.2 Key Development

11.4.3 Financial Insight

11.5 Boston Scientific Corporation

11.5.1 Overview

11.5.2 Key Development

11.5.3 Financial Insight

11.6 Medtronic plc

11.6.1 Overview

11.6.2 Key Development

11.6.3 Financial Insight

11.7 Hologic, Inc.

11.7.1 Overview

11.7.2 Key Development

11.7.3 Financial Insight

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting